Clinical Trials Browser

Interventional × Hearing Loss × CNS × Clear all

Neurofibromatosis 2, Hearing Loss

NCT06517888 2026-04-06

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2 Recruiting

27 enrolled

CNS

Neuroma, Acoustic, Hearing Loss

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

Clinical Trials

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2